10x Genomics (TXG) Stock: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$68.59
2.21 (3.33%)
▲
5d:
+8.49%
30d:
+18.77%
90d:
+136.11%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.90
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$6.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $68.59, which is considered extended relative to its 30-day fair value range of $53.40 to $65.96. From a valuation perspective, the stock is trading at a premium (Forward PE: 337.4) compared to its historical average (170.3). At these levels, the market is pricing in 25.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TXG is in a strong uptrend. The price is approaching resistance at $69.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $51.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TXG is in a strong uptrend. The price is approaching resistance at $69.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $51.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$53.40 -
$65.96
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.4%
Protect Your Profits
Holding TXG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BEARISH: Trading 25.6% above Wall St target ($51.00)
- BEARISH: Market expects 25.6% growth - appears too optimistic based on history
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$53.40 -
$65.96
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$58.70
Resistance Level
$69.67
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
337.38
Wall Street Target
$51.00
(-25.6%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-12.2%
Valuation Premium vs History
+25.6% premium
PE vs Historical
337.4 vs 170.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+25.6%
(market-implied from PE analysis)
1-Year Target
$86.15
(+26%)
2-Year Target
$108.20
(+58%)
3-Year Target
$135.90
(+98%)
3-Yr Target (if PE normalizes)
(PE: 337→170)
PE COMPRESSION
$68.60
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 337.4, Growth: 93.6%)
$231.49
(+238%)
Base:
(SPY PE: 20.2, Growth: 93.6%)
$13.84
(-80%)
Bear:
(PE: 17.1, Growth: 93.6%)
$11.76
(-83%)
Share & Embed Analysis
Last updated: September 11, 2026 8:31 PM ET
Data refreshes hourly during market hours. Next update: 9:31 PM
Data refreshes hourly during market hours. Next update: 9:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
Advanced TXG Option Strategies
Professional options setups generated by AI based on today's TXG price and gamma walls.
